The purpose of this study is to evaluate the efficacy of Diclofenac Sodium Topical (DSG) 1% compared with placebo applied four times a day in subjects with acute ankle sprains under 'in-use' conditions, in particular with regard to pain relief.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
206
Diclofenac sodium topical gel 1%, 4 times daily
Placebo, 4 times daily
Unnamed facility
Birmingham, Alabama, United States
Unnamed facility
Aventura, Florida, United States
Unnamed facility
Hialeah, Florida, United States
Unnamed facility
Miami, Florida, United States
Pain on Movement
Pain on movement at 72 hours assessed on a 100 mm visual analog scale with anchors at 0= "No pain" and 100= "Extreme pain"
Time frame: 72 hours
Pain on Movement
Pain on movement at 24 hours and 7 days assessed on a 100 mm visual analog scale with anchors at 0= "No pain" and 100= "Extreme pain"
Time frame: 24 hours and 7 days
Onset of Pain Relief
Onset of perceptible pain relief
Time frame: Day 1
Tenderness
Tenderness at 24 and 72 hours and 7 days. Change from baseline. Tenderness was measured by a calibrated algometer in order to quantify the pressure pain threshold, a measure of tenderness.
Time frame: Change from baseline at 24 and 72 hours, 7 days
Ankle Joint Function
Ankle joint function score (Karlsson Scoring scale which ranges from 0 "worst possible score" to 90 "best possible score")at 24 and 72 hours and 7 days.
Time frame: 24 and 72 hours, 7 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Unnamed facility
Berlin, New Jersey, United States
Unnamed facility
Columbia, South Carolina, United States
Unnamed facility
El Paso, Texas, United States
Unnamed facility
Houston, Texas, United States
Unnamed facility
Salt Lake City, Utah, United States